Skip to content

Association between HPV infection and penile cancer and penile intraepithelial neoplasia: A retrospective observational study

Penile cancer is rising in most European countries. Several risk factors have been identified, namely human papillomavirus (HPV) infection. However, the exact role of HPV in penile cancer carcinogenesis is still unknown. Clarifying the contribution of HPV in penile cancer is crucial as it may improve prevention and treatment strategies.
Read more

Test scientific paper right here

Seegene USA is a leading developer of multiplex molecular assays and automated solutions for US labs. Seegene aims to support a healthy life for everyone by creating a new diagnostic paradigm.

Read more

Is it a Tripledemic? An Update on RSV/Flu/COVID-19 Testing and Patient Care

RSV is the most common single cause of respiratory hospitalization of infants and is the second largest cause of lower respiratory infection mortality worldwide. This year RSV rates are exceeding the usual number of cases, exacerbated by the immunity gap of the SARS-CoV-2 pandemic. As a result, healthcare resources are being stretched, creating new challenges.
Read more

Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing

The World Health Organization (WHO) has called for the elimination of cervical cancer as a public health problem. Cervical cancer screening through human papillomavirus (HPV) testing is a core component of the strategy for elimination, with a set target of screening 70% of women twice in their lifetimes. In this review, we discuss technical barriers and opportunities to increase HPV screening globally.
Read more

Retrospective and Comparative Study of Three Molecular Assays for the Macrolide Resistance Detection in Mycoplasma genitalium Positive Urogenital Specimens

The capacity of Mycoplasma genitalium to develop resistance to macrolides makes detection of macrolide resistance genes by rapid real-time PCR assays increasingly necessary in clinical diagnostic laboratories so as to initiate appropriate treatment as rapidly as possible. The aim of this retrospective and comparative study was to conduct the clinical evaluation of three commercially available kits for macrolide resistance detection.
Read more

Clinical Performance of Three Commercial Molecular Diagnostic Assays for the Detection of Fluoroquinolone Resistance-Associated Mutations in Mycoplasma genitalium

In the absence of Ser83Ile (G248T) and mutations at position at 83 and 87 in parC, the probability of moxifloxacin cure of macrolide-resistant Mycoplasma genitalium was 96.4% and 97.8%, respectively. This suggests that selection of antibiotics via testing the existence of parC mutation using Allplex™ MG & MoxiR Assay is essential in increasing the treatment efficiency of Mycoplasma genitalium.
Read more

New Normal: Surveillance and Epidemiology of Severe Acute Respiratory Pathogens using Seegene Novaplex™ Respiratory Multiplex PCR

In the United States, population-based surveillance for hospitalized cases of laboratory-confirmed influenza is conducted in 14 sites. However, surveillance for other causes of severe acute respiratory illness (SARI) is not well established. The Minnesota Department of Health (MDH) participates in ongoing hospital-based surveillance to characterize and monitor SARI.
Read more

Low prevalence of macrolide resistance in Mycoplasma genitalium infections in a cohort of pregnant women living with human immunodeficiency virus

Macrolide resistance in Mycoplasma genitalium (M. genitalium) is increasing as a result of the widespread use of azithromycin in the treatment of sexually transmitted infections (STIs). To date, there are few published studies on macrolide resistance patterns in South African pregnant women. This study now contributes to the growing body of knowledge.
Read more
Back To Top